CTMX vs VTRS · rev $11.7M vs rev $7.27B
CytomX Therapeutics Inc (CTMX) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
CTMX currently screens at market cap $653.1M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the CTMX and VTRS stock pages for the full models.
Not investment advice.